Earnings estimate | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 0 | 0 | 2 | 2 |
Avg. Estimate | 0 | 0 | 0.77 | 1.21 |
Low estimate | 0 | 0 | 0.68 | 0.99 |
High estimate | 0 | 0 | 0.86 | 1.42 |
Year ago EPS | N/A | N/A | 0.2 | 0.77 |
Revenue estimate | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 3 | 0 | 3 | 3 |
Avg. Estimate | 244.03M | N/A | 244.03M | 287.4M |
Low estimate | 239M | N/A | 239M | 275.69M |
High estimate | 254M | N/A | 254M | 298M |
Year ago sales | 212.01M | N/A | 212.01M | 244.03M |
Sales growth (year/est) | 15.10% | N/A | 15.10% | 17.80% |
Earnings history | Invalid Date | Invalid Date | Invalid Date | Invalid Date |
---|---|---|---|---|
Est. EPS | N/A | N/A | N/A | N/A |
Actual EPS | N/A | N/A | N/A | N/A |
Difference | N/A | N/A | N/A | N/A |
Surprise % | N/A | N/A | N/A | N/A |
EPS trend | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Current estimate | 0 | 0 | 0.77 | 1.21 |
7 days ago | 0 | 0 | 0.68 | 1.42 |
30 days ago | 0 | 0 | 0.83 | 1.39 |
60 days ago | 0 | 0 | 0.98 | 1.56 |
90 days ago | 0 | 0 | 0.77 | 1.53 |
EPS revisions | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | MED.SW | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | N/A | N/A | N/A | N/A |
Next qtr. | N/A | N/A | N/A | N/A |
Current year | 285.00% | N/A | N/A | N/A |
Next year | 57.10% | N/A | N/A | N/A |
Next 5 years (per annum) | N/A | N/A | N/A | N/A |
Past 5 years (per annum) | N/A | N/A | N/A | N/A |